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The average UK adult consumes less than three portions of fruit and vegetables daily, despite
evidence to suggest that consuming five portions daily could help prevent chronic diseases. It is
recommended that fruit juice should only count as one of these portions, as juicing removes
fibre and releases sugars. However, fruit juices contain beneficial compounds such as vitamin C
and flavonoids and could be a useful source of dietary phytochemicals. Two randomised
controlled cross-over intervention studies investigating the effects of chronic and acute con-
sumption of commercially-available fruit- and vegetable-puree-based drinks (FVPD) on bio-
availability, antioxidant status and CVD risk factors are described. Blood and urine samples
were collected during both studies and vascular tone was measured using laser Doppler ima-
ging. In the chronic intervention study FVPD consumption was found to significantly increase
dietary carotenoids (P = 0.001) and vitamin C (P = 0.003). Plasma carotenoids were increased
(P = 0.001), but the increase in plasma vitamin C was not significant. There were no significant
effects on oxidative stress, antioxidant status and other CVD risk factors. In the acute inter-
vention study FVPD were found to increase total plasma nitrate and nitrite (P = 0.001) and
plasma vitamin C (P = 0.002). There was no effect on plasma lipids or uric acid, but there was
a lower glucose and insulin peak concentration after consumption of the FVPD compared with
the sugar-matched control. There was a trend towards increased vasodilation following both
chronic and acute FVPD consumption. All volunteers were retrospectively genotyped for the
eNOS G298T polymorphism and the effect of genotype on the measurements is discussed.
Overall, there was a non-significant trend towards increased endothelium-dependent vasodila-
tion following both acute and chronic FVPD consumption. However, there was a significant
time · treatment effect (P<0.05) of acute FVPD consumption in individuals with the GG
variant of the eNOS gene.
Carotenoids: Flavonoids: CVD: Laser Doppler imaging
CVD is one of the major causes of death in Europe and is
responsible for 4.3 · 106 deaths each year across the con-
tinent(1). One of the emerging risk factors for CVD is
dysfunction of the endothelium(2,3), which is characterised
by a reduction in the bioavailability of vasodilators, pre-
dominantly NO, endothelium-derived hyperpolarizing fac-
tor and prostacyclin, and an increase in endothelium-derived
vasoconstrictors, e.g. thromboxane A2, PGH2 and endothelin
1(2). Endothelial dysfunction can be assessed by measuring
enhanced and maintained endothelial activation and impair-
ed endothelium-dependent vasodilation(4).
Endothelial activation is determined by an increase in
the plasma concentrations of soluble cell adhesion mole-
cules, such as intercellular adhesion molecule-1, vascular
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cell adhesion molecule-1, E-selectin and P-selectin, because
these molecules are shed and released into the plasma from
the activated endothelium. Elevated concentrations of these
molecules have been found in patients with all types of
CVD and those patients who have not developed CVD but
display coronary risk factors such as smoking, hyperten-
sion, hypercholesterolaemia and diabetes mellitus(5). Con-
sequently, endothelial dysfunction is thought to represent a
key early stage in the development of atherosclerosis.
Impaired endothelium-dependent vasodilation in patients
with CVD was first reported in 1986(6). When acetylcho-
line was injected into the coronary arteries of patients vaso-
constriction was found instead of the expected relaxation
and vasodilation response. Established cardiac risk factors
such as age, gender, hypertension, hyperlipidaemia, dia-
betes mellitus and smoking, as well as novel risk factors
such as inflammation and hyperhomocysteinaemia, have
all been associated with abnormal vasorelaxation(7). There
are now substantial data relating impaired endothelial vaso-
motor function to CHD(8). Assessment of coronary artery
endothelial function is commonly achieved by intracor-
onary infusion of acetylcholine, as it causes release of
NO and consequently coronary artery dilation(7). Patients
with risk factors for atherosclerosis exhibit a diminished
vasodilatory response to acetylcholine or paradoxical vaso-
constriction(6). Non-invasive methods of assessing endo-
thelial-dependent vasodilation have now been developed(9).
The most frequently used are flow-mediated dilation and
laser Doppler imaging with iontophoresis.
The flow-mediated dilation technique uses ultrasonic
assessment of brachial artery flow during hyperaemia(7).
Essentially, forearm or hand ischaemia is induced when the
arterial blood supply is interrupted with a cuff inflated to
suprasystolic pressure. When the tourniquet is released
dilation of the distal microvasculature induces reactive
hyperaemia. NO is released locally as a result of the shear
stress and changes in hydrostatic pressure during the
hyperaemia. The extent of endothelial function is then
elucidated from the magnitude of the change in vessel
diameter from baseline to the peak observed during reac-
tive hyperaemia.
It has recently been determined that endothelial dys-
function also occurs in the peripheral circulation and the
extent of dysfunction is proportional to that occurring in
the coronary arteries(10). Iontophoresis is a technique of
investigating the vasodilation of the peripheral micro-
vasculature by delivering vasodilator agents across the skin
under the influence of an applied electrical field. Ionto-
phoresis coupled with laser Doppler flowmetry has been
used as a non-invasive technique for measuring micro-
vascular perfusion at a single point(11). However, an
emerging method combining iontophoresis with laser
Doppler imaging enables the measurement of perfusion
across many points and an average measure of perfusion
can then be calculated for a given area(11). Acetylcholine is
administered at the anode and tests endothelial function via
its vasodilator action of binding to muscarinic receptors on
endothelial cells and subsequently generating NO; con-
sequently, acetylcholine is known as an ‘endothelium-
dependent’ vasodilator. As vasodilation is ultimately
mediated by the action of NO on vascular smooth muscle
a NO donor, sodium nitroprusside, is administered at
the cathode. This compound is used as an ‘endothelium-
independent’ vasodilator and acts as a control to test the
integrity of vascular smooth muscle. Examination of the
dilation response of skin microvasculature to acetylcholine
and sodium nitroprusside has shown that the local vasodi-
latory response is reduced in patients with peripheral
arterial occlusive disease compared with age- and gender-
matched healthy controls(12).
The effects of phytochemicals from fruits and
vegetables on endothelial dysfunction
There are several components of fruit and vegetables
that have been shown to exert favourable effects on vas-
cular endothelial function, either by improving endothe-
lium-dependent vasodilation or by decreasing endothelial
activation. These components include: folic acid(13); the
antioxidant vitamins C (ascorbic acid) and E (a-tocoph-
erol)(14,15); polyphenols(16,17); carotenoids(18); fibre(19).
The effects of folic acid on endothelial dysfunction. Re-
search has shown that folic acid can have a beneficial
effect on the vascular endothelium by reducing plasma
homocysteine levels(13). This effect is a result of the role of
folic acid during the methylation of homocysteine to
methionine(20). Homocysteine has several detrimental
effects on the vascular endothelium, which include: increas-
ing platelet aggregation and thrombosis(4); increasing oxi-
dative stress by increasing superoxide production(21); down
regulating NO production(22); increasing vascular smooth
muscle proliferation(23); increasing leucocyte–endothelium
interactions(24).
There have been several clinical studies that have
investigated the effects of folic acid supplementation on
endothelial function. It has been reported that when sub-
jects who are mildly hyperhomocysteinaemic are supple-
mented with folic acid (5 mg/d) and pyridoxine (250 mg/d)
over a 12-week period a decrease is found in both plasma
von Willebrand factor and thrombomodulin(25). Another
study in which subjects received folic acid (5 mg/d) chose
to investigate forty subjects with familial hypercholester-
olaemia(26). After 4 weeks it was found that folic acid
supplementation restores endothelium-dependent vasodila-
tion, as assessed by serotonin-induced forearm blood flow
measurement. In a further intervention study eighteen
subjects with hyperhomocysteinaemia were given 5 mg
folic acid daily during a 6-week intervention period(27).
Flow-mediated vasodilation of the brachial artery was
measured and it was found that supplementation improves
endothelium-dependent vasodilation.
Two intervention studies of folic acid supplementation
have been reported that used healthy subjects(13,28). Both
studies used 10 mg folic acid/d or placebo and measured
the outcome by flow-mediated vasodilation of the brachial
artery. One study comprising seventeen subjects with an
intervention period of 8 weeks has shown an improvement
in endothelium-dependent vasodilation(28). The other study
of twenty subjects who received the supplement for a
2-week period carried out vasomotion measurements on
each subject before and 4 h after an oral fat load (50 g, in
the form of whipped cream)(13). It was found that folic acid
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supplementation prevents vasodilation impairment after a
fat load.
These supplementation studies suggest that folic acid
has a beneficial effect on endothelial function, as measured
by haemostatic markers or flow-mediated vasodilation.
Although it is suggested that the observations are a result
of reduced homocysteine concentrations, other mechan-
isms may also contribute to the effects.
The effects of vitamins C and E on endothelial dysfunc-
tion. Endothelial function may be modulated by anti-
oxidant vitamins such as vitamin C and vitamin E. Animal
experiments have shown that one form of vitamin E, a-
tocopherol, preserves NO-mediated vascular relaxation in
subjects with hypercholesterolaemia(29,30). In vitro studies
with antioxidant vitamins have shown that vitamin E
reduces cell adhesion molecule expression(31) and mono-
cyte adhesion to the endothelium(32) and vitamin C leads to
improvement in endothelium-dependent vasodilation(33).
A number of clinical studies have investigated the
effects of antioxidant supplementation, in the form of
vitamins C or E, on markers of endothelial activation or
endothelium-dependent vasodilation. These studies have
found a decrease in monocyte adhesion with both vitamin
C(34) and vitamin E(14), and plasma P-selectin is reduced
in subjects with hypercholesterolaemia following a-toco-
pherol supplementation(35). It has been reported that infu-
sion with vitamin C leads to an increase in forearm blood
flow of 1.4 ml/100 ml per min in subjects after a 6 h hyper-
glycaemic clamp(36). Vitamin C supplementation has been
shown to improve endothelium-dependent vasodilation,
measured by flow-mediated dilation, from 4.2 (SE 0.7) %
to 9.1 (SE 1.3) % in subjects with chronic heart fail-
ure(37) and from 6.6 (SD 3.5) % to 10.1 (SD 5.2) % in
subjects with coronary artery disease(38). In healthy sub-
jects in whom hyperhomocysteinaemia has been induced
with an oral methionine load the reduction in flow-medi-
ated dilation can be ameliorated by pre-treatment with
vitamin C supplementation of 1000 mg/d for 1 week(15). In
smokers supplemented with vitamin E (545 mg all-racemic
a-tocopherol/d) there is an improvement in flow-mediated
vasodilation of 5.8 (SD 3.2) % for the supplemented group
v. 2.7 (SD 2.8) % for the placebo group(39).
Dilation of blood vessels occurs when endothelial cells
generate NO(4). This molecule can react with superoxide
generated by endothelial cells during cytoplasmic and
mitochondrial metabolism to form peroxynitrite, which
is destructive to cells(40). Antioxidants could therefore
decrease this consumption of NO and render it bioavailable
for vasodilation(41). However, it has been found that high
physiological concentrations of vitamin C (>1 mM) are
needed to effectively scavenge superoxide and enhance
endothelium-dependent vasodilation(42). Vitamin C could
augment delivery of NO from the plasma to the vascular
cells(43). NO can be transported as S-nitrosothiols on
albumin or free cysteine(44) and vitamin C can release NO
from S-nitrosothiols and S-nitrosoalbumin(45). However, as
most of the free NO is likely to be scavenged by Hb and
erythrocytes(46,47) further investigations are required to
determine whether sufficient NO can be released by this
mechanism to promote vasodilation. Another mechanism
whereby vitamin C could increase vasodilation is by
regulating endothelial NO synthase (eNOS) by increasing
the affinity of eNOS for tetrahydrobiopterin(48). This out-
come could be achieved by preserving crucial thiol groups
on eNOS, which are needed in order to bind tetra-
hydrobiopterin(49), or by reducing the redox cycling of
tetrahydrobiopterin by decreasing cellular superoxide or
peroxynitrite(50).
Overall, the studies generally show a supportive role for
antioxidant vitamins C and E in preserving endothelium-
dependent vasodilation. This effect is particularly evident
in subjects with cardiovascular risk factors such as hyper-
lipidaemia or in patients with diabetes or established CVD.
The effects of carotenoids on endothelial dysfunc-
tion. The addition of tomato to the diet has been reported
to have a protective effect on acetylcholine-induced
vasorelaxation in hypercholesterolaemic mice fed on an
atherogenic diet(18). Mice fed a diet high in saturated fat
and cholesterol for 4 months were found to have an
increased plasma lipid peroxide level and a decreased
vasorelaxing activity in the aorta induced by acetylcholine
compared with mice on a commercial diet. However, when
20% (w/w) powdered tomato was added to the atherogenic
diet a lesser increase in the plasma lipid peroxide level
was found and acetylcholine-induced vasorelaxation was
maintained at the same level as that for normal mice.
Although it was concluded that tomato has a preventive
effect on atherosclerosis by protecting plasma lipids from
oxidation, the nature of the protective factor in the tomato
could not be determined. However, it was noted that
tomatoes contain a relatively large amount of the caro-
tenoid lycopene and that the tomato powder used in the
study contained 1.6 mg lycopene/g. Based on a report that
indicates that lycopene supplementation inhibits singlet-
oxygen-mediated oxidation of human plasma LDL(51) and
the finding that the uptake of tomato reduces the increase
in plasma lipid peroxide in hypercholesterolaemic mice, it
was suggested that lycopene might act as an antioxidant in
plasma(18). However, plasma lycopene was not measured
in the mouse study and it was noted that carotenoids are
thought to be less absorbed by rodents than by human
subjects. Thus, it was concluded that the findings strongly
suggest that dietary ingestion of tomato inhibits the oxi-
dative modification of serum lipids and subsequently
reduces endothelial dysfunction(18).
The evidence in support of a preventative function of
lycopene in CVD primarily originates from epidemiologi-
cal observations in normal and at-risk populations. The
most powerful population-based evidence has been derived
from a European multicentre case–control study(52). This
study investigated the relationship between acute myo-
cardial infarction and adipose tissue antioxidant status.
Levels of a- and b-carotenes, lycopene and a-tocopherol
were measured in adipose tissue collected shortly after the
infarction. However, after adjustment for age, BMI, socio-
economic status, smoking, hypertension and family history
of the disease, only lycopene levels were found to be pro-
tective. The results show a dose–response relationship
between each quintile of adipose tissue lycopene content
and the risk of myocardial infarction.
Although the European multicentre case–control study
observed no protective effect of b-carotene or a-tocopherol
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on myocardial infarction(52), other research has shown
that these lipophilic antioxidants preserve endothelium-
dependent relaxation in cholesterol-fed rabbits(53). Male
rabbits were divided into four groups; one group was fed a
commercial diet, another group received the commercial
diet with 1% (w/w) cholesterol added and the final two
groups received the 1% (w/w) cholesterol diet with either
b-carotene (0.6 g/kg chow) or a-tocopherol (1000 mg a-
tocopheryl acetate/kg chow). After 28 d on the diets thora-
cic aortas were collected and analysed for vascular function
and tissue antioxidant levels. Acetylcholine-induced vaso-
relaxation was found to be significantly impaired in vessels
from the cholesterol group (P<0.001), whereas vessels
from the animals supplemented with b-carotene or a-
tocopherol displayed normal arterial relaxation. Pre-
servation of vasorelaxation was found to be associated with
vascular incorporation of b-carotene and a-tocopherol, but
unrelated to plasma lipoprotein levels, smooth muscle cell
function or the extent of atherosclerosis. Increased LDL
resistance to ex vivo Cu-mediated oxidation was only
found in the a-tocopherol group. As dysfunction in endo-
thelium-dependent vasorelaxation is associated with risk of
CVD(10), this research may suggest that the benefit of diets
containing carotenoids on this risk factor may be through
vascular tissue antioxidant content and not associated with
the resistance of LDL to ex vivo oxidation.
The pro-vitamin A activity of b-carotene is well
known(54) and vitamin A derivatives, particularly all-trans-
retinoic acid (atRA), have been shown to inhibit cellular
proliferation and promote cellular differentiation(55). In the
latter study it was found that atRA increases NO synthesis
by endothelial cells. Murine endothelioma cells treated
with or without atRA were found to show a maximum
increase in nitrite production 24 h after stimulation with
atRA. eNOS mRNA expression was not found to increase
after treatment with atRA and there was no detectable
eNOS or inducible NO synthase mRNA in the cells. The
effect of atRA on the induction of the dimethylarginine
dimethylaminohydrolase enzymes that regulate asymmetric
dimethylarginine metabolism was also investigated. Di-
methylarginine is an endogenous competitive inhibitor of
NOS and dimethylarginine dimethylaminohydrolase II
has been shown to be highly expressed in cardiovascular
tissues and to have a distribution similar to eNOS(56). It
was found that dimethylarginine dimethylaminohydrolase
II expression is induced by atRA, with the maximum
increase occurring 12 h after stimulation(55). This effect
was also observed in primary porcine aortic endothelial
cells and the human cell lines SGHEC-7 (SV40 transfected
human umbilical vein endothelial cells) and ECV304. As
raised levels of dimethylarginine have been shown to be
associated with endothelial dysfunction and athero-
sclerosis(57,58) it was suggested that induction of dimethyl-
arginine dimethylaminohydrolase II by atRA may lower
dimethylarginine levels and consequently restore NO pro-
duction.
These studies support the epidemiological findings that
carotenoid-containing foods may be beneficial in reducing
the risk of CVD(59). However, they suggest that their mode
of action may not be entirely a result of their antioxidant
properties.
The effects of polyphenols on endothelial dys-
function. In 1993 it was reported that grape juice and
grape-skin extracts cause endothelium-dependent vaso-
relaxation(60). The study focused on the effect of certain
wines, grape juices and grape-skin extracts on pre-
contracted smooth muscle of rat aortic rings. Relaxation
was found in intact aortic rings, but no effect was observed
on aortas in which the endothelium had been removed. The
polyphenolic compounds quercetin and tannic acid were
found to produce endothelium-dependent relaxation. The
grape extracts were found to increase cGMP levels in the
intact vascular tissue. Both relaxation and the increase in
cGMP were reversed by NG-monomethyl-L-arginine and
NG-nitro-L-arginine, which are competitive inhibitors of
NO synthesis. These findings suggest that grape-product-
induced vasorelaxation is mediated by the NO–cGMP
pathway. To further investigate the effect of various plant
extracts on endothelium-dependent vasorelaxation aqueous
extracts of numerous fruits, vegetables, nuts, herbs, spices
and teas were studied(61). It was found that many of, but
not all, these extracts exhibit endothelium-dependent re-
laxation that is again reversed in the presence of a NO
synthase inhibitor.
Following on from the initial work with grape products
performed on rat aorta(60,61), other studies on various iso-
lated animal and human blood vessels have reached similar
conclusions(62). These studies used a variety of plant
polyphenol sources such as cocoa, tea, hawthorn (Cra-
taegus monogyna and Crataegus oxyacantha fruit), honey
and pine (Pinus maritima) bark. All these studies have
found that plant polyphenols produce endothelium-depen-
dent vasorelaxation that is associated with increased cGMP
formation and reduced by NO synthase inhibitors.
Structure–activity (endothelial NO release and relax-
ation of isolated blood vessels) relationships for different
classes of polyphenols have been examined(16,17). The most
active fractions in red wine were found to be flavan-3-ol-
enriched oligomeric condensed tannins, particularly dimers
and trimers, and the most active monomer was the antho-
cyanin delphinidin(16). Surprisingly, structurally-similar
anthocyanins, such as malvidin and cyanidin, were not
found to be active. However, substitution of the flavan
moiety with free hydroxyl residues at precise locations has
been found to be important to induce endothelial NO
release(17).
The mechanisms of eNOS activation in response to cir-
culating hormones, local autacoids and substances released
by platelets, by the coagulation cascade and by the auto-
nomic nervous system involve intracellular Ca2 + (63). This
role of Ca2 + is supported by the relaxation of rat aorta(64)
and the increase in Ca2 + concentration in bovine aortic
endothelial cells(65) caused by a polyphenolic extract from
alcohol-free red wine and by delphinidin, which are both
Ca2 + dependent effects. Furthermore, wine polyphenols
are unable to increase Ca2 + concentration in smooth muscle
cells, indicating the selectivity of this effect(65).
Long-term incubation of endothelial cells with red
wine increases eNOS expression(66,67). This effect is only
achieved, however, with large volumes of red wine (1%
(v/v) in culture medium for 10 d, 3% (v/v) for 24 h and
10% (v/v) for 12 h)(67). Resveratrol, also a polyphenolic
Fruit and vegetables and endothelial dysfunction 151
P
ro
ce
ed
in
gs
o
f
th
e
N
u
tr
it
io
n
So
ci
et
y
component of red wine, stimulates eNOS expression in the
concentration range of 10–100mM, as well as increasing
the activity of the eNOS promoter and stabilising eNOS
mRNA(66).
In a study of the incorporation of elderberry (fruit of
elder; Sambucus nigra) anthocyanins by bovine and human
aortic endothelial cells treated with an elderberry extract
(1 mg/ml) and incubated for 1, 2, 4, 6, 8, 16 and 24 h, maxi-
mum incorporation was found after 4 h(68). By separation
of the cell membranes and cytosol it was demonstrated that
the anthocyanins were incorporated into the plasma mem-
brane as well as penetrating into the cell cytosol. Uptake
into both regions was found to be structure dependent, with
monoglycoside concentrations higher than those of the
diglucosides. The incorporation of elderberry anthocyanins
was found to be protective against H2O2, 2,2
0-azobis(2-
amidinopropane) dihydrochloride and FeSO4–ascorbic
acid.
A protective effect of blackberry (Rubus fruticosus)
anthocyanins, notably cyanidin-3-O-glucoside, on endo-
thelial cells has also been reported(69). In this study the
effect of peroxynitrite on human umbilical vein endothelial
cells incubated with differing concentrations of blackberry
juice was investigated. It was found that blackberry juice
reduces the peroxynitrite-induced suppression of mito-
chondrial respiration, DNA damage and poly (ADP-ribose)
synthetase activation in human umbilical vein endothelial
cells. It was also reported that vascular rings exposed to
peroxynitrite demonstrate reduced endothelium-dependent
relaxant responses to acetylcholine, which is improved by
the blackberry juice.
In addition to research with endothelial cells, poly-
phenols have also been incubated with platelets(70). Incu-
bation of platelets with diluted purple-grape juice leads to
inhibition of aggregation, enhanced release of platelet-
derived NO and decreased superoxide production(70). In
order to investigate these effects in vivo, an intervention
trial was conducted in which twenty healthy subjects con-
sumed 7 ml purple-grape juice/kg daily for 14 d. Following
the intervention platelet aggregation was found to be
inhibited, platelet-derived NO production increased from
3.5 pmol/108 platelets to 6.0 pmol/108 platelets and super-
oxide release decreased from 29.5 arbitrary units to 19.2
arbitrary units. It was also reported that a-tocopherol levels
significantly increase and plasma protein-independent
antioxidant activity increases by 50%.
Other intervention trials have investigated the effect of a
range of polyphenols on endothelial dysfunction(71,72). In a
study of the effects of white and red wines on the endo-
thelial function of fourteen subjects with coronary artery
disease 4 ml wine/kg was administered alongside a con-
trolled meal low in antioxidants(71). Measurement of flow-
mediated dilation of the brachial artery indicated an
improvement in dilation after 360 min, although no differ-
ence was found between the two types of wine. Con-
sumption of an isoenergetic cordial was not found to
improve dilation. No difference in plasma polyphenols was
observed in blood samples taken at baseline, 60 min and
360 min after consumption of either type of wine.
In another study of patients with coronary artery disease
fifty patients with proven coronary artery disease underwent
an intervention trial of black tea consumption(72). Short-
term effects were measured by examining the subjects 2 h
after consumption of 450 ml tea or water and long-term
effects were measured after consumption of 900 ml tea or
water daily for 4 weeks. Measurements of flow-mediated
vasodilation of the brachial artery showed improvement
with both the short- and long-term tea consumption,
whereas water was found to have no effect. Administration
of an equivalent oral dose of caffeine was not found to
have any short-term effect on flow-mediated vasodilation.
Plasma concentrations of flavonoids were shown to in-
crease after both the short- and long-term tea consumption.
Although tea contains antioxidant flavonoids, studies have
shown that tea consumption has no effect on plasma anti-
oxidant capacity, plasma concentrations of F2-isoprostanes,
markers of systemic lipid peroxidation or 8-hydro-
xydeoxyguanosine(73).
Many fruits and vegetables contain polyphenolic flavo-
noid compounds(74,75), some of which have been shown to
increase the activity of the eNOS enzyme(76). eNOS is
responsible for the generation of the vasodilator NO from
L-arginine in the vascular endothelium(77). A common sin-
gle-nucleotide polymorphism (G298T) occurs in the eNOS
gene that modifies its coding sequence, replacing a gluta-
mate residue at position 298 with an aspartate residue, and
this polymorphism has been linked to increased risk of
cardiovascular events(78–82).
Two studies have been conducted to investigate the
effects of chronic and acute consumption of commercially-
available fruit and vegetable puree-based drinks (FVPD)
on vasodilation, phytochemical bioavailability and anti-
oxidant status in healthy individuals aged between 30 and
70 years (TW George, C Niwat, S Waroonphan, MH
Gordon and JA Lovegrove, unpublished results; TW
George, E Paterson, S Waroonphan, MH Gordon and JA
Lovegrove, unpublished results). FVPD were chosen to
provide a convenient source of fruit and vegetable nu-
trients and phytochemicals such as vitamin C and flavo-
noids. FVPD enabled all the participants to receive a
standardised product throughout the duration of the studies,
which would have been difficult to achieve with fresh
produce. The participants of both studies were retro-
spectively genotyped for the G298T polymorphism and
their endothelium-dependent vasodilation responses re-
analysed in relation to genotype.
Materials and methods
Study participants
Thirty-nine participants completed the chronic study
(twenty-four females and fifteen males, mean age (years)
45 (SD 9) and 44 (SD 11) respectively) and twenty-four
completed the acute study (twenty males and four females,
mean age (years) 46 (SD 11) and 49 (SD 4) respectively).
The participants in both studies were recruited if they met
the criteria: no known liver disease, diabetes mellitus or a
diagnosed mycocardial infarction; no gall bladder pro-
blems or abnormalities of fat metabolism; no subjects on
weight-reducing diets or taking dietary supplements; no
vigorous exercise or excess consumption of alcohol; BMI
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<30 kg/m2; blood pressure <150/90 mmHg and Hb
>125 g/l. Basic anthropometric measurements were recor-
ded for all study participants and fasting blood was taken
and analysed for liver function status, lipid levels, fasting
glucose and a measure of potential alcohol abuse. The
studies were approved by the University of Reading
Research Ethics Committee and each participant gave
informed consent before participating.
Study designs
The chronic study was a single-blind randomised con-
trolled cross-over dietary study. After a 1-week run-in
period with control drink (lemon barley water; Robinsons
Ltd, Chelmsford, Essex, UK), the participants consumed
the test intervention of two FVPD (Vie shots; Unilever
Bestfoods GmbH, Ansbach, Germany) per d or a control
drink of diluted fruit-flavoured cordial for a 6-week period
(for details of drinks, see later). After 8 weeks the par-
ticipants were asked to repeat the intervention but con-
suming the other drink. Participants completed two 5 d diet
records (four weekdays and one weekend day) during each
cross-over arm of the study (four diaries in total for each
subject). Fasting plasma and urine samples were collected
at baseline and at the end of the intervention period in each
arm of the study. In addition, a real-time measure of vas-
cular tone using laser Doppler iontophoresis before and
after the intervention period was performed on a subset of
the participants (n 19) in one arm of the study in a parallel
study design.
The acute study was a single-blind controlled cross-over
dietary study. The participants consumed a low-flavonoid
diet for the 5 d preceding the study day. On the study day a
flexible cannula was inserted into the forearm and blood
samples were taken at baseline and at twelve additional
time points after consumption of the relevant drink (eight
samples 30 min apart followed by four samples 1 h apart).
Urine was collected before the drink (FVPD or sugar-
matched control) was consumed and then at two-hourly
intervals for the 8 h of the study day. Laser Doppler ion-
tophoresis measurements were recorded at baseline and at
five 90 min intervals following drink consumption. The
whole procedure was repeated with the other intervention
drink after a 4-week washout period.
Intervention drinks
For the chronic study participants were asked to consume
two bottles (2 · 100 ml) of FVPD daily. The FVPD were
fruit and vegetable preparations made from purees and
concentrated juices, which contained the equivalent of
200 g fruit and vegetables per bottle. Participants were
asked to consume daily one bottle of apple, carrot and
strawberry and one bottle of orange, banana and carrot
drink. The control drink was either orange or lemon barley
water (50 ml diluted to 400 ml with mineral water (The
Buxton Mineral Water Co. Ltd, Buxton, Derby., UK)
daily). The nutrient composition of the FVPD and the
control drinks is shown in Tables 1 and 2 respectively.
For the acute study participants were asked to consume
400 ml FVPD (apple, carrot and strawberry) or 50 ml
fruit-flavoured cordial (lemon barley water), which was
matched for sugar composition and diluted with mineral
water (The Buxton Mineral Water Co. Ltd).
Blood sample collection
Blood samples were collected into separate vacutainer
tubes containing citrate, EDTA and heparin anticoagulants,
which were immediately wrapped in foil and kept on
ice for transport to the laboratory. Each subject’s blood
samples were centrifuged at 4C at 3000 rpm immediately
after collection, plasma and buffy coat were retained, ali-
quots of plasma were put into separate cryogenic vials for
storage and all samples were frozen for future analysis.
The objective of this approach was to minimise oxidative
changes within the plasma sample before storage at
- 80C. Analyses were not carried out until the interven-
tion study had been completed and then all samples for
each subject were analysed within one batch to reduce
inter-batch variation.
Table 1. Nutrient composition (/100 ml) of fruit- and vegetable-
puree-based drinks
Apple, carrot
and strawberry*
Orange, banana
and carrot*
Energy (kJ) 264 335
Protein (g) 1.0 2.0
Carbohydrate (g) 13.6 17.0
Sugars (g) 12.6 15.8
Fat (g) 0.5 0.4
Saturates (g) 0.1 0.1
Fibre (g) 1.5 1.5
Na (g) 0.03 0.02
Ascorbic acid (mg) 36.0 48.5
Total carotenoids (mg) 5.1 6.6
a-Carotene (mg) 1.5 1.9
b-Carotene (mg) 2.6 3.3
Nitrate and nitrite (mg) 0.19 –
*Vie shots; Unilever Bestfoods GmbH, Ansbach, Germany.
Table 2. Nutrient composition (/50 ml) of control drinks
Lemon
barley
water*
Orange
barley
water*
Acute
study
control drink†
Energy (kJ) 48 49 203
Protein (g) 0.2 0.2 0.3
Carbohydrate (g) 10.9 11.6 50.4
Sugars (g) 9.9 10.6 50.4
Fat (g) Trace Trace Trace
Saturates (g) 0 0 Trace
Fibre (g) 0.1 Trace 0.1
Na (g) Trace Trace Trace
Ascorbic acid (mg) – – Trace
Nitrate and nitrite (mg) 0.0 – 0.0
*Robinsons Ltd, Chelmsford, Essex, UK.
†50 ml fruit-flavoured cordial (lemon barley water; Robinsons Ltd), which was
matched for sugar composition and diluted with mineral water (The Buxton
Mineral Water Co. Ltd, Buxton, Derby., UK).
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Laser Doppler imaging with iontophoresis
Vascular reactivity was recorded for a subgroup of nine-
teen of the thirty-nine participants in the chronic study and
for all twenty-four participants in the acute study. Measure-
ments were taken with each subject in a supine position in
a quiet room maintained at an ambient temperature of
221C. Two ION6 chambers (Moor Instruments Ltd,
Axminster, Devon, UK) were placed on the forearm and
connected to a MIC2 iontophoresis controller (Moor
Instruments Ltd). Acetylcholine chloride (Sigma Aldrich,
Poole, Dorset, UK; 2.5 ml; 1% (w/v) in 0.5% (w/v) NaCl
solution) was placed in the anodal chamber and sodium
nitroprusside (Sigma Aldrich; 2.5 ml; 1% (w/v) in 0.5%
(w/v) NaCl solution) was placed in the cathodal chamber.
Current delivery was controlled by laser Doppler imager
Windows software (Moor Instruments Ltd). Measurement
of skin perfusion was carried out using a laser Doppler
imager (moorLDI2; Moor Instruments Ltd). Repeat scans
were taken with increasing current, to give a total charge
of 8 mC. The area under the flux v. time curve represented
the microvascular response.
Plasma lipid profiles and plasma glucose
Analyses of plasma TAG, total cholesterol, HDL-choles-
terol, NEFA and glucose hexokinase were performed using
an Instrument Laboratory ILAB 600 autoanalyzer and
standard kits (Instrumental Laboratories Ltd, Warrington,
Ches., UK). Appropriate sero-normal, low- and high-quality
control standards (Instrument Laboratories Ltd) were
included in all batches.
Plasma insulin
Insulin was assessed by ELISA (Dako Cytomation, Ely,
Cambs., UK) with in-house pooled plasma controls in each
batch.
Plasma ascorbic acid and uric acid
Plasma samples were treated with an equal volume of 10%
(v/v) metaphosphoric acid, centrifuged at 12 000 rpm for
10 min and the supernatant fraction stored at - 80C before
analysis for ascorbic acid by HPLC with UV detection(83)
and simultaneous determination of uric acid(84).
Plasma carotenoids and tocopherols
Plasma carotenoids and tocopherols were measured by
the method of Thurnam et al.(85) using a Hewlett Packard
1050 HPLC system with a Nucleosil 100-5C18 column
(250 mm · 46 mm; Hichrom Ltd, Reading, Berks., UK) at
a flow rate of 1.5 ml/min and the detector set to monitor
at 292 nm for a- and g-tocopherol, 450 nm for lutein,
b-cryptoxanthin, a-carotene and b-carotene and 472 nm for
lycopene.
Total nitrite and nitrate
Total nitrate and nitrite was measured using an ELISA kit
(Active Motif, Rixensart, Belgium) based on the Greiss
reaction(86) for plasma, FVPD and the control drink.
Analysis of Glu298Asp polymorphism
DNA was isolated from the buffy coat layer of 10 ml blood
collected in an EDTA vacutainer using the Qiagen DNA
Blood Mini Kit (Qiagen Ltd, Crawley, West Sussex, UK).
Allelic discrimination of the eNOS gene variants was
conducted using TaqMan PCR technology (7300 Instru-
ment; Applied Biosystems, Warrington, Ches., UK) and
Assay-on-Demand SNP genotyping assays (Applied Bio-
systems).
Dietary analysis
The diet diaries were analysed using Diet Cruncher nut-
ritional analysis software (Way Down South Software,
Dunedin, New Zealand) in combination with an electronic
version of the McCance and Widdowson 6th edition food
composition database (Food Standards Agency, London,
UK).
Statistical analyses
All statistical analyses were performed using SPSS 13.0 for
Microsoft Windows (SPSS Inc., Chicago, IL, USA). The
data were assessed for normality using the Shapiro–Wilk
test, as the number of subjects was less than fifty. Those
data that were not normally distributed were log trans-
formed and reassessed. A repeated measure ANOVA was
used to test for differences between treatment groups, with
Bonferroni correction to reduce the likelihood of chance
findings from multiple comparisons. A value of P £ 0.05
was used to define significance and a 95% CI. The data are
presented as means with their standard errors, unless
otherwise stated.
Results
Chronic FVPD consumption
Table 3 summarises the major findings from the chronic
FVPD consumption study. There was a significant increase
in dietary carotenoids and ascorbic acid following FVPD
consumption (P = 0.001 and P = 0.003 respectively). There
was an increase in plasma carotenoids and ascorbic acid,
which was significant for plasma carotenoids (P = 0.001).
There was no significant effect of FVPD on measures of
oxidative stress, oxidative stability, lipid profiles, plasma
homocysteine, von Willebrand factor, C-reactive protein or
on the susceptibility of LDL particles to oxidation (data
not shown).
Acute FVPD consumption
The participants exhibited a lower glucose and insulin
peak concentration after consumption of the FVPD com-
pared with the sugar-matched control (Figs. 1 and 2
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respectively). There was a significant time · treatment
effect on plasma glucose and insulin (P = 0.019 and P =
0.003 respectively). There was a significant time-
treatment effect of FVPD consumption on plasma ascorbic
acid and total plasma nitrate and nitrite (P = 0.002 (Fig. 3)
and P = 0.001 (Fig. 4) respectively). There was a sig-
nificant increase in plasma ascorbic acid from 60 min until
the end of the study day (Fig. 3). There was an increase in
total plasma nitrate and nitrite at all time points following
FVPD consumption (Fig. 4).
There was no effect of FVPD ingestion on plasma TAG,
HDL-cholesterol, total cholesterol or NEFA compared with
control drink consumption (data not shown).
Effect of G298T polymorphism on vasodilation
Table 4 shows the distribution of the different G298T
genotypes among participants in the chronic and acute
studies. In the chronic study laser Doppler iontophoresis
measurements were recorded in a subgroup of nineteen
participants (seven GG, eleven GT and one TT). In the
acute study the genotype distribution of the twenty-four
participants was eleven GG, eleven GT and two TT. There
were only two individuals with the TT genotype in the
acute study and one in the chronic study; because of lack
of power these individuals were excluded from any statis-
tical analysis.
The increase in endothelium-dependent vasodilation
induced by acetylcholine after 6 weeks of FVPD con-
sumption compared with the control intervention when all
the subjects (seven control and eleven FVPD) were com-
bined did not reach significance (P = 0.079), and there was
no significant effect of treatment when the genotypes were
examined individually (Fig. 5). There was a significant
time · treatment effect (P<0.05) of acute FVPD con-
sumption for the GG genotype. After post-hoc tests there
was significantly higher endothelium-dependent vasodila-
tion after 180 min (Fig. 6; P = 0.028). There was no effect
of FVPD on endothelium-dependent vasodilation for indi-
viduals with the GT genotype. There was no effect of
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Fig. 1. Plasma glucose concentration (mmol/l; n 24) following acute consumption of fruit- and vegetable-puree-
based drinks (400 ml apple, carrot and strawberry (Vie shots; Unilever Bestfoods GmbH, Ansbach, Germany);
&––&) or control (50 ml fruit-flavoured cordial (lemon barley water; Robinsons Ltd, Chelmsford, Essex, UK),
which was matched for sugar composition and diluted with mineral water (The Buxton Mineral Water Co. Ltd,
Buxton, Derby., UK); ^- - -^). Values are means with their standard errors represented by vertical bars. The
time · treatment effect was significant (P = 0.019). The between-treatment effect was significant (after post-hoc
tests): *P<0.05.
Table 3. Summary of dietary and plasma carotenoid and ascorbic acid concentrations before and after 6 weeks of chronic consumption of
fruit- and vegetable-puree-based drinks (FVPD) or control (n 39)*
Control FVPD
P†
Week 0 Week 6 Week 0 Week 6
Mean SE Mean SE Mean SE Mean SE
Dietary total carotenoids (mg/d) 3239 2710 2648 1927 2522 1914 13852 2573 0.001
Dietary ascorbic acid (mg/d) 117 63 101 60 114 53 154 42 0.003
Plasma a-carotene (mmol/l) 0.25 0.16 0.22 0.13 0.20 0.11 0.96 0.45 0.001
Plasma b-carotene (mmol/l) 0.34 0.23 0.32 0.22 0.32 0.23 0.76 0.46 0.001
Plasma ascorbic acid (mmol/l) 91 37 81 36 89 32 97 4 NS
*The FVDP drink was one 100 ml bottle of apple, carrot and strawberry and one 100 ml bottle of orange, banana and carrot (Vie shots; Unilever Bestfoods GmbH,
Ansbach, Germany) daily and the control drink was 50 ml lemon barley water (Robinsons Ltd, Chelmsford, Essex, UK) diluted to 400 ml with mineral water (The
Buxton Mineral Water Co. Ltd, Buxton, Derby., UK) daily. For details of studies, see text.
†Change over time in the FVPD group.
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FVPD on endothelium-independent vasodilation induced
by sodium nitroprusside (data not shown).
Discussion
The objective of the present research was to investigate the
chronic and acute effects of FVPD consumption on vaso-
dilation, bioavailability of phytochemicals and ascorbic
acid and risk factors for CVD. The chronic consumption of
FVPD resulted in an increase in dietary carotenoids and
ascorbic acid. The significant increase in plasma car-
otenoids, notably a- and b-carotene, showed that the diet-
ary carotenoids present in the FVPD were absorbed after
ingestion. There was no effect of the FVPD on antioxidant
status or markers of oxidative stress. It is speculated that
this lack of findings could have reflected the preference of
the participants to consume the FVPD in the morning,
approximately 24 h before they gave a fasted blood sample
and morning urine sample. Thus, many of the components
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Fig. 2. Plasma insulin concentration (pmol/l; n 24) following acute consumption of fruit- and vegetable-puree-
based drinks (400 ml apple, carrot and strawberry (Vie shots; Unilever Bestfoods GmbH, Ansbach, Germany);
&––&) or control (50 ml fruit-flavoured cordial (lemon barley water; Robinsons Ltd, Chelmsford, Essex, UK),
which was matched for sugar composition and diluted with mineral water (The Buxton Mineral Water Co. Ltd,
Buxton, Derby., UK); ^- - -^). Values are means with their standard errors represented by vertical bars. The
time · treatment effect was significant (P = 0.003). The between-treatment effect was significant (after post-hoc
tests): *P<0.05.
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Fig. 3. Plasma ascorbic acid concentration (mmol/l; n 24) following acute consumption of fruit- and
vegetable-puree-based drinks (400 ml apple, carrot and strawberry (Vie shots; Unilever Bestfoods
GmbH, Ansbach, Germany); &) or control (50 ml fruit-flavoured cordial (lemon barley water; Robinsons
Ltd, Chelmsford, Essex, UK), which was matched for sugar composition and diluted with mineral water
(The Buxton Mineral Water Co. Ltd, Buxton, Derby., UK); ). Values are means with their standard
errors represented by vertical bars. The time · treatment effect was significant (P = 0.002). The
between-treatment effect was significant (after post-hoc tests): *P<0.05.
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of the FVPD would have been metabolised and would no
longer be present in the plasma, having limited effect on
the antioxidant status or markers of oxidative stress.
Consequently, a second study was performed which in-
volved acute ingestion of FVPD, with blood samples were
taken throughout the study day. The participants followed
a low-flavonoid diet for the 5 d preceding the study day to
ensure there was a low background level of these phyto-
chemicals present in the plasma before FVPD consump-
tion. There was an increase in antioxidant status during the
first 4 h after FVPD consumption (data not shown), which
was consistent with previous studies(87). The participants
displayed a lower glucose and insulin peak concentration
after consumption of the FVPD compared with the sugar-
matched control. The FVPD was prepared from con-
centrated juices and purees, so there may have been an
effect of the fruit and vegetable matrix on the availability
of the sugars present in the FVPD compared with the
control drink in which the sugars were in solution in
mineral water. There was an increase in plasma ascorbic
acid throughout the day following FVPD consumption,
which could have contributed to the increase in antioxidant
status. Total plasma nitrate and nitrite was also increased
following FVPD and remained higher throughout the
day compared with the control. The increase in plasma
nitrate and nitrite may have been a result of increased
NO production or increased NO sparing. The FVPD was
a potential source of flavonoid compounds, particularly
(–)-epicatechin derived from the 56% (v/v) apple content,
which has been shown to increase eNOS activity by
scavenging superoxide(76).
After the two studies had been completed the partici-
pants were retrospectively genotyped for the G298T poly-
morphism in the eNOS gene. After chronic consumption
of FVPD there was an increase in endothelium-dependent
vasodilation induced by acetylcholine, but there was in-
sufficient power to test the effect of genotype. In the acute
study there was a significant increase in endothelium-
dependent vasodilation in participants with the GG geno-
type 180 min after FVPD consumption. There was no
effect of FVPD consumption on endothelium-dependent
vasodilation in participants with the GT genotype or on
endothelium-independent vasodilation for either genotype.
This result is comparable with findings from venous
occlusion plethysmography(88), which have shown that the
change in forearm blood flow ratio between the infused
and the control arm in response to acetylcholine is
decreased in healthy individuals with the GT genotype
compared with those with GG variants (3.79 (SD 2.28),
P = 0.07 v. 3.97 (SD 1.90), P = 0.04 respectively) and that
there is no effect of genotype on the response to the
endothelium-independent vasodilator sodium nitroprusside.
In conclusion, the current studies suggest that con-
sumption of the equivalent of five portions of fruit and
vegetables in the form of puree and fruit juice concentrates
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Fig. 4. Total plasma nitrate and nitrite concentration (mmol/l; n 24) following acute consumption of fruit-
and vegetable-puree-based drinks (400 ml apple, carrot and strawberry (Vie shots; Unilever Bestfoods
GmbH, Ansbach, Germany); &) or control (50 ml fruit-flavoured cordial (lemon barley water; Robinsons
Ltd, Chelmsford, Essex, UK), which was matched for sugar composition and diluted with mineral water
(The Buxton Mineral Water Co. Ltd, Buxton, Derby., UK); ). Values are means with their standard errors
represented by vertical bars. The time · treatment effect was significant (P = 0.001). The between-
treatment effect was significant (after post-hoc tests): *P<0.05.
Table 4. Distribution of G298T genotypes among subjects partici-
pating in studies of the chronic and acute consumption of fruit- and
vegetable-puree-based drinks*
G298T genotypes
GG GT TT
Chronic study 7 11 1
(3 M, 4 F) (2 M, 9 F) (1 M)
Acute study 11 11 2
(9 M, 2 F) (10 M, 1 F) (1 M, 1 F)
M, males; F, females.
*For details of studies, see text.
Fruit and vegetables and endothelial dysfunction 157
P
ro
ce
ed
in
gs
o
f
th
e
N
u
tr
it
io
n
So
ci
et
y
0100
200
300
400
500
600
GG Control  (n 3) GG FVPD (n 4) GT Control   (n 5) GT FVPD (n 6)
Response after 6 weeks of drink consumption
En
do
th
el
iu
m
-d
ep
en
de
nt
 v
as
od
ila
tio
n 
IA
UC
(%
 ch
an
ge
 fro
m 
ba
se
lin
e)
Fig. 5. Endothelium-dependent vasodilation response to acetylcholine of participants with GG
(n 7) and GT (n 11) genotype after 6 weeks of intervention with either control (50 ml lemon or
orange barley water (Robinsons Ltd, Chelmsford, Essex, UK) diluted to 400 ml with mineral
water (The Buxton Mineral Water Co. Ltd, Buxton, Derby., UK) daily; K) or fruit- and vege-
table-puree-based drinks (FVPD; one 100 ml bottle of apple, carrot and strawberry and one
100 ml bottle of orange, banana and carrot (Vie shots; Unilever Bestfoods GmbH, Ansbach,
Germany) daily; &).Values are means with their standard errors represented by vertical bars.
Data are shown as the percentage from baseline of the incremental area under the curve
(IAUC) of the repeated scans by laser Doppler imaging with iontophoresis.
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Fig. 6. Endothelium-dependent vasodilation response to acetylcholine of partici-
pants (n 22) with GG (K, ; n 11) and GT ( , &; n 11) genotype after acute
ingestion of either control (50 ml lemon barley water (Robinsons Ltd, Chelmsford,
Essex, UK), which was matched for sugar composition and diluted with mineral
water (The Buxton Mineral Water Co. Ltd, Buxton, Derby., UK); K, ) or fruit- and
vegetable-puree-based drinks (FVPD; 400 ml apple, carrot and strawberry (Vie
shots; Unilever Bestfoods GmbH, Ansbach, Germany); , &). Values are means
with their standard errors represented by vertical bars. Data are shown as the
percentage from baseline of the incremental area under the curve (IAUC) of the
repeated scans by laser Doppler imaging with iontophoresis. The time · treatment
effect was significant for GG individuals (P = 0.05). The between-treatment effect
was significant (after post-hoc tests): *P<0.05.
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increases dietary phytochemicals and micronutrients when
consumed chronically and increases dietary phytochem-
icals, micronutrients, plasma antioxidant status and total
nitrate and nitrite concentrations when consumed acutely.
FVPD consumption has a beneficial effect on endothelium-
dependent vasodilation for individuals with the GG variant
of the eNOS gene. This research supports previous data
suggesting that the G298T polymorphism is associated
with reduced endothelium-dependent vasodilation in healthy
subjects that is not affected by fruit and vegetable con-
sumption. Further research is required to investigate the
effects of genotype in relation to chronic fruit and
vegetable consumption and endothelium-dependent vaso-
dilation.
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